newsfilter
← Latest News
GlobeNewswire·

NeuBase Therapeutics Reports Financial Results for the Second Quarter of Fiscal Year 2021

Extended cash runway into CY2023 following completion of an equity financing from leading healthcare investors generating $42.6 million in net proceeds; supports advancing the Company's lead program into the clinic and scaling of its precision genetic m